Skip to content

Transcranial Direct Current Stimulation and Robotic Therapy in Upper Limb Motor Recovery After Stroke

Transcranial Direct Current Stimulation and Robotic Therapy in Upper Limb Motor Recovery After Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02496026
Enrollment
20
Registered
2015-07-14
Start date
2014-07-31
Completion date
2017-12-22
Last updated
2020-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

The objective of the study is to evaluate the effectiveness of transcranial direct current stimulation (tDCS) integrated with wrist robot-assisted treatment. In detail, the anodal stimulation on the impaired hemisphere will be used associated with a robotic treatment.

Detailed description

As for transcranial direct current stimulation a HDC kit (ATES/EB NEURO, Firenze, Italy) will be used as device. It is a new device generation of stimulator able to provide an effective stimulation pattern. As robotic device the InMotion wrist robot (Interactive Motion Technologies Inc., Watertown, MA, USA) will be used. It is an end-effector robotic device able to assist as needed the wrist movements.

Interventions

DEVICEtDCS plus wrist robot therapy

Patients receive robotic rehabilitation session while tDCS stimulator is switched on

DEVICESham tDCS plus wrist robot therapy

Patients receive robotic rehabilitation session while tDCS stimulator is switched off.

Sponsors

Auxilium Vitae Volterra
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

1. persons affected by first supratentorial stroke, whose onset time is 25±7 days; 2. upper limb hemiparesis; 3. cognitive and speech abilities sufficient to understand instructions and to provide informed consent; 4. absence of intense pain due to passive wrist mobilization assessed by VAS \< 3 (range 0-10); 5. ability to provide written informed consent.

Exclusion criteria

1. previous epilepsy seizures; 2. severe electroencephalographic anomalies; 3. previous neurosurgery interventions involving metallic elements placement; 4. ongoing anticonvulsant drugs treatment 5. inability to keep sitting posture; 6. severe sensory deficits; 7. general clinical complication preventing delivery of rehabilitation treatment.

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in the motor impairment as assessed by the Fugl-Meyer Motor Assessment Scale (upper extremity subsection)6 weeksImpairment level measure according to ICF

Secondary

MeasureTime frameDescription
Change from Baseline in the motor impairment as assessed by the Fugl-Meyer Motor Assessment Scale (upper extremity subsection)6 monthsImpairment level measure according to ICF
Change from Baseline in the upper limb functional and motor abilities as assessed by the Motricity Index6 weeksImpairment level measure according to ICF
Change from Baseline in the upper limb spasticity as assessed by the Modified Ashworth Scale6 weeksImpairment level measure according to ICF
Change from Baseline in the unilateral gross manual dexterity as assessed by the Block and Box test6 weeksActivities level measure according to ICF

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026